Thermo Fisher Scientific

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 07:29:36 18/06/2024 pm IST			5-day change	1st Jan Change
569.2 ^USD	+0.21%		-0.77%	+7.66%

17/06	Devyser Diagnostics AB Announces Expanded Commercial Agreement with Thermo Fisher Scientific for Post-Transplant Monitoring NGS Products	CI
12/06	Thermo Fisher Scientific Introduces Thermo Scientific Heracell VIOS 250i AxD CO2 Incubators	CI

Thermo Fisher Scientific Inc. Declares Quarterly Dividend, Payable on July 15, 2024

May 23, 2024 at 02:55 am IST

Thermo Fisher Scientific Inc. announced that its Board of Directors authorized a quarterly cash dividend of $0.39 per common share, payable on July 15, 2024, to shareholders of record as of June 14, 2024.

Latest news about Thermo Fisher Scientific

Devyser Diagnostics AB Announces Expanded Commercial Agreement with Thermo Fisher Scientific for Post-Transplant Monitoring NGS Products	17/06	CI
Thermo Fisher Scientific Introduces Thermo Scientific Heracell VIOS 250i AxD CO2 Incubators	12/06	CI
Thermo Fisher Scientific Insider Sold Shares Worth $11,374,358, According to a Recent SEC Filing	06/06	MT
Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research	03/06	CI
Thermo Fisher Scientific Opens New GMP-Certified Ultra-Cold Facility in the EU to Accelerate Advanced Therapies Development	03/06	CI
Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions to Comply with IVDR Regulation	31/05	CI
Declaration of Voting Results by Thermo Fisher Scientific Inc	25/05	CI
Thermo Fisher Scientific Keeps Quarterly Dividend of $0.39 a Share, Payable July 15 to Shareholders of Record on June 14	23/05	MT
Thermo Fisher Scientific Inc. Declares Quarterly Dividend, Payable on July 15, 2024	23/05	CI
Thermo Fisher Scientific Introduces Array-Based Solution for Extended Blood Type Research to Support Future Advancements Toward Safer Transfusions	15/05	CI
Transcript : Thermo Fisher Scientific Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM	14/05
UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger	10/05	MT
UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink	10/05	MT
UK's CMA kicks off probe into Thermo Fisher-Olink deal	10/05	RE
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip	08/05	RE
Thermo Fisher Scientific Insider Sold Shares Worth $5,737,356, According to a Recent SEC Filing	03/05	MT
Jefferies Adjusts Price Target on Thermo Fisher Scientific to $600 From $540	01/05	MT
Thermo Fisher Scientific Insider Sold Shares Worth $1,135,880, According to a Recent SEC Filing	30/04	MT
HSBC Raises Thermo Fisher Scientific's Price Target to $670 From $660	30/04	MT
Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific	29/04	MT
Bio-Techne Corporation Announces New Distribution Agreement with Thermo Fisher Scientific	29/04	CI
Raymond James Adjusts Price Target on Thermo Fisher Scientific to $650 From $605, Keeps Outperform Rating	29/04	MT
Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $620 From $615	26/04	MT
Deutsche Bank Adjusts Price Target on Thermo Fisher Scientific to $610 From $600	25/04	MT
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $648 From $644	25/04	MT

Chart Thermo Fisher Scientific

Duration

Period

More charts

Company Profile

Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

24/07/2024 - Q2 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Thermo Fisher Scientific

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

568 USD

Average target price

629.5 USD

Spread / Average Target

+10.82%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+7.66%	22TCr
DANAHER CORPORATION	+11.08%	19TCr
INTUITIVE SURGICAL, INC.	+28.22%	15TCr
BOSTON SCIENTIFIC CORPORATION	+30.93%	11TCr
SIEMENS HEALTHINEERS AG	-0.84%	6.28TCr
EDWARDS LIFESCIENCES CORPORATION	+14.16%	5.23TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+1.85%	4.93TCr
GE HEALTHCARE TECHNOLOGIES INC.	+0.97%	3.54TCr
RESMED, INC.	+23.27%	3.09TCr
PHILIPS NV	+17.71%	2.4TCr

Other Advanced Medical Equipment & Technology